Shelia Violette
Gründer bei Q32 Bio, Inc.
Vermögen: 56 904 $ am 30.04.2024
Profil
Shelia Violette is the founder of Q32 Bio, Inc. (Massachusetts) and Q32 Bio, Inc., both founded in 2017.
She holds the title of Chief Scientific Officer at Q32 Bio, Inc. (Massachusetts) and Chief Scientific Officer & President-Research at Q32 Bio, Inc. Currently, Dr. Violette is an Advisor at Atlas Venture Advisors, Inc. since 2021.
Previously, she worked as an Immunology Director at Biogen, Inc., Director at CytImmune Sciences, Inc. from 2021 to 2023, Principal at Repligen Corp., Principal at ARIAD Pharmaceuticals, Inc., and Vice President-Research at Stromedix, Inc. Dr. Violette obtained her doctorate degree from Yale University in 1989.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,02% | 25.03.2024 | 2 015 ( 0,02% ) | 56 904 $ | 30.04.2024 |
Aktive Positionen von Shelia Violette
| Unternehmen | Position | Beginn |
|---|---|---|
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Gründer | 01.01.2017 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Berater | 01.01.2021 |
Ehemalige bekannte Positionen von Shelia Violette
| Unternehmen | Position | Ende |
|---|---|---|
CytImmune Sciences, Inc.
 CytImmune Sciences, Inc. BiotechnologyHealth Technology CytImmune Sciences, Inc. operates as a clinical stage oncology company. It develops and manufactures cytokine immunoassay kits. The company was founded by Lawrence Tamarkin and Giulio F. Paciotti in 1998 and is headquartered in Rockville, MD. | Direktor/Vorstandsmitglied | 01.06.2023 |
| BIOGEN INC. | Corporate Officer/Principal | - |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| REPLIGEN CORPORATION | Corporate Officer/Principal | - |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Shelia Violette
| Yale University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| BIOGEN INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Stromedix, Inc.
Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
CytImmune Sciences, Inc.
CytImmune Sciences, Inc. BiotechnologyHealth Technology CytImmune Sciences, Inc. operates as a clinical stage oncology company. It develops and manufactures cytokine immunoassay kits. The company was founded by Lawrence Tamarkin and Giulio F. Paciotti in 1998 and is headquartered in Rockville, MD. | Health Technology |
